Geode Capital Management’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.13M Buy
618,119
+21,871
+4% +$328K ﹤0.01% 2488
2025
Q4
$9.21M Buy
596,248
+36,516
+7% +$488K ﹤0.01% 2450
2025
Q3
$5.77M Buy
559,732
+74,570
+15% +$703K ﹤0.01% 2706
2025
Q2
$5.41M Buy
485,162
+149,595
+45% +$1.87M ﹤0.01% 2689
2025
Q1
$4.12M Buy
335,567
+12,594
+4% +$158K ﹤0.01% 2742
2024
Q4
$3.61M Buy
322,973
+5,781
+2% +$50.3K ﹤0.01% 2901
2024
Q3
$2.21M Buy
317,192
+25,330
+9% +$185K ﹤0.01% 3088
2024
Q2
$2.21M Buy
291,862
+174,902
+150% +$1.76M ﹤0.01% 3101
2024
Q1
$1.54M Buy
116,960
+964
+0.8% +$13.8K ﹤0.01% 3213
2023
Q4
$1.2M Buy
115,996
+5,787
+5% +$46.2K ﹤0.01% 3286
2023
Q3
$1.07M Buy
110,209
+38,694
+54% +$227K ﹤0.01% 3287
2023
Q2
$321K Hold
71,515
﹤0.01% 3827
2023
Q1
$332K Hold
71,515
﹤0.01% 3811
2022
Q4
$106K Buy
71,515
+5,945
+9% +$13.2K ﹤0.01% 4378
2022
Q3
$245K Hold
65,570
﹤0.01% 4087
2022
Q2
$324K Sell
65,570
-51,298
-44% -$339K ﹤0.01% 3991
2022
Q1
$959K Sell
116,868
-1,988
-2% -$17.2K ﹤0.01% 3638
2021
Q4
$1.2M Buy
118,856
+896
+0.8% +$11.6K ﹤0.01% 3628
2021
Q3
$1.87M Buy
117,960
+6,980
+6% +$147K ﹤0.01% 3376
2021
Q2
$2.64M Buy
+110,980
New +$2.58M ﹤0.01% 3180

Other funds holding NPCE

Geode Capital Management's NPCE Position: Q1 2026 in Review

Geode Capital Management increased its Neuropace (NPCE) stake by 3.7% in Q1 2026, buying an estimated $328K and bringing the position to 618,119 shares worth $8.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

Geode Capital Management first reported a position in NPCE in Q2 2021 and has held it in 20 quarters since. The position peaked at $9.21M in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Geode Capital Management held 618,119 shares of Neuropace worth $8.13M as of Q1 2026.
  • Geode Capital Management bought 21,871 Neuropace shares in Q1 2026, an estimated $328K.
  • Neuropace made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2488 holding.
  • Geode Capital Management first reported a position in Neuropace in Q2 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Neuropace position peaked at $9.21M in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.